This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Geraghty, P. J. Search for Related Content PubMed PubMed Citation Articles by Geraghty, P. J. Social Bookmarking                         What's this?

Covered Stenting of the Superficial Femoral Artery Using the Viabahn Stent-Graft

St Louis, MO

High initial technical success rates for superficial femoral artery revascularization are possible using multiple modalities. For these interventions to pose a serious challenge to open surgical bypass, improved primary patency in mid- and long-term follow-up must be achieved. In several smaller studies, covered stenting of the superficial femoral artery has shown superior patency at 2 years after intervention. The ongoing VIBRANT trial randomizes patients to superficial femoral artery intervention with either bare nitinol stents or Viabahn covered stents. The 3-year outcomes data from this trial will better define the role of percutaneous intervention for complex superficial femoral artery disease.

Key Words: femoral artery revascularization • covered stent-graft • Viabahn stent

References

• 1. Dawson DL, Cutler BS, Meissner MH, Strandness DE, Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98:678-686, 1998.[Abstract/Free Full Text]
• 2. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 27:267-274; discussion 274-5, 1998.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 3. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 274(12):975-980, 1995.[Abstract/Free Full Text]
• 4. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31:S1-296, 2000.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 5. Laird J, Jaff MR, Biamino G, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol 16:1067-1073, 2005.[Web of Science][Medline] [Order article via Infotrieve]
• 6. Zeller T, Rastan A, Schwarzwalder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther 11:676-685, 2004.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 7. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45:312-315, 2005.[Abstract/Free Full Text]
• 8. Mewissen MW. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol 7:2-5, 2004.[CrossRef][Medline] [Order article via Infotrieve]
• 9. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16:331-338, 2005.[Web of Science][Medline] [Order article via Infotrieve]
• 10. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002; 106:1505-1509.[Abstract/Free Full Text]
• 11. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 14:303-311, 2003.[Web of Science][Medline] [Order article via Infotrieve]
• 12. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 14(1):41-51, 2003.[Web of Science][Medline] [Order article via Infotrieve]

Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 18, No. 1, 39-43 (2006)
DOI: 10.1177/153100350601800117


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. N. Lesperance, N. N. Singh, T. K. Curry, and C. A. Andersen Retrograde Stent-Graft Angioplasty of Superficial Femoral Artery Occlusion in a Claudicant Vascular and Endovascular Surgery, February 1, 2009; 43(1): 83 - 86. [Abstract] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Geraghty, P. J. Search for Related Content PubMed PubMed Citation Articles by Geraghty, P. J. Social Bookmarking                         What's this?